Unequal Progress in Early-Onset Bladder Cancer Control: Global Trends, Socioeconomic Disparities, and Policy Efficiency from 1990 to 2021
Zhuofan Nan, Weiguang Zhao, Shengzhou Li, Chaoyan Yue, Xiangqian Cao, Chenkai Yang, Yilin Yan, Fenyong Sun, Bing Shen

TL;DR
This study shows that early-onset bladder cancer is increasing globally, especially in middle-income countries, with significant disparities and the need for better prevention and resource allocation.
Contribution
The study introduces decomposition and SDI-efficiency frontier analyses to assess EOBC trends and policy performance.
Findings
EOBC incidence, prevalence, and DALYs increased significantly from 1990 to 2021, with the highest burden in middle-SDI regions.
Males had over twice the burden of females, with the highest rates in the 45–49 age group.
Smoking was the leading risk factor, while hyperglycemia burdens rose in high-income areas.
Abstract
Background: This study investigates the global burden of early-onset bladder cancer (EOBC) from 1990 to 2021, highlighting regional disparities and the growing role of metabolic risk factors. Early-onset bladder cancer (EOBC), diagnosed before age 50, is an emerging global health concern. While less common than kidney cancer, EOBC contributes substantially to mortality and disability-adjusted life years (DALYs), with marked sex disparities. Its global epidemiology remains unassessed systematically. Methods: Using GBD 1990–2021 data, we analyzed EOBC incidence, prevalence, mortality, and DALYs across 204 countries in individuals aged 15–49. Trends were examined via segmented regression, EAPC, and Bayesian age-period-cohort modeling. Inequality was quantified using SII and CI. Decomposition and SDI-efficiency frontier analyses were introduced. Results: From 1990 to 2021, EOBC incidence…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBladder and Urothelial Cancer Treatments · Urinary Tract Infections Management · Urinary Bladder and Prostate Research
